Thank you for connecting with Cencora at AMCP Annual 2026. Our teams met with managed care leaders, payers, and biopharma partners to discuss evolving access challenges and share insights focused on supporting informed healthcare decision‑making.
Thought leadership in action
Spotlight session:
Eye on the Future: Exploring the Latest Payer Trends in Cell and Gene Therapies and Anti-Obesity Medications
Discussion around how U.S. payers are managing access and formulary decisions for cell and gene therapies and anti‑obesity medications. Drawing on two recent Cencora studies, we will share insights from health plans, PBMs, and IDNs on coverage trends, utilization management, evidence needs, and future expectations, providing biopharma and managed care stakeholders with practical guidance to navigate an evolving payer landscape.
AI session:
Unlocking AI's potential in managed care: an actionable roadmap
As AI adoption accelerates, this session explored how AI is reshaping managed care pharmacy today and what to expect by 2030. We’ll review key challenges (fragmented data, formulary inefficiencies, and demand for personalized, value-based care), highlight current AI solutions, and outline what’s next —predictive analytics, automated utilization management, enhanced patient engagement, and more real-time payer decision-making — with a practical roadmap for stakeholders.
Lunch & Learn session:
Enhancing your PIE Strategy with Healthcare Decision-Maker Insights
Our Cencora | FormularyDecisions® experts hosted a strategy session unveiling the latest market research trends on PIE, real-world insights from payers on how pre-approval information is used in decision-making, and newly available platform data on engagement with pipeline features.
Network & Learn session:
The Afternoon Shake Up: what’s changing in pipeline, policy, and digital transformation with FormularyDecisions
In this session, we explored the forces shaping formulary decision-making across three fast-moving fronts: the pharmacy pipeline including the expansion of anti-obesity medications, health policy and regulation, digital transformation, and AI-enabled workflows.
See our research and insights from the expo
Poster 123
Title: Payer perspectives on manufacturer-led direct-to-consumer (DTC) offerings for anti-obesity medications (AOMs)
Authors: Shaila Yoshida, Arvin Sequeira, Michelle Friedman
Poster 206
Title: Practice efficiency and institutional costs associated with epcoritamab + rituximab + lenalidomide in patients with relapsed or refractory follicular lymphoma
Authors: Qianyi Li, Savreet Bains Chawla (Genmab US), Kellie Meyer, Monika Jun (Genmab US ), Felipe Marques Goncalves (Genmab US ), Matthew Lei (Massachusetts General Hospital)
Title: Payer perspectives on manufacturer-led direct-to-consumer (DTC) offerings for anti-obesity medications (AOMs)
Authors: Shaila Yoshida, Arvin Sequeira, Michelle Friedman
Poster 206
Title: Practice efficiency and institutional costs associated with epcoritamab + rituximab + lenalidomide in patients with relapsed or refractory follicular lymphoma
Authors: Qianyi Li, Savreet Bains Chawla (Genmab US), Kellie Meyer, Monika Jun (Genmab US ), Felipe Marques Goncalves (Genmab US ), Matthew Lei (Massachusetts General Hospital)
Innovation and Impact Awards
During AMCP Annual 2026, we were proud to recognize organizations and partners who demonstrate innovation, collaboration, and leadership through our Innovation and Impact Awards.
In an evolving healthcare landscape, these award recipients exemplify forward‑thinking approaches that support better decision‑making and improved patient access. We congratulate this year’s honorees on their achievements.
Congratulations to Synexis (Emerging Biopharma) and Vertex (Mid-to-large Biopharma) for setting the standard.
In an evolving healthcare landscape, these award recipients exemplify forward‑thinking approaches that support better decision‑making and improved patient access. We congratulate this year’s honorees on their achievements.
Congratulations to Synexis (Emerging Biopharma) and Vertex (Mid-to-large Biopharma) for setting the standard.
Insights from FormularyDecisions | Cencora and AMCP
Webinar
Preparing for 2026 health policy changes and their impact on pricing, affordability, and access
FormularyDecisions | Cencora and AMCP hosted an insightful webinar on how managed care organizations and biopharmaceutical companies are reimagining ways to deliver sustained value and protect future innovation amid significant health policy changes.
FormularyDecisions® delivers unrivaled opportunities for biopharma companies to reach out to, and connect with, payers
Drive awareness
In the current landscape, it’s harder than ever for biopharma companies to get in-person meetings with payers. FormularyDecisions enables easy outreach to, and engagement with, these critical stakeholders.
Increase engagement
Biopharma companies who fully take advantage of the FormularyDecisions platform and all its features enjoy greater levels of engagement with the payer community, helping build a stronger level of awareness and relationships with payers.
Leverage and understand insights
With direct real-time feedback from payers on a product, biopharma companies can get a better understanding of payer perceptions and refine their information so it resonates better with payers.
Monitor competition
With unparalleled insights into how their product compares with direct competitors, biopharma companies get a full view of the landscape in the therapeutic space, and learn what they can do to stay ahead of the curve.
Partner with experts in strategic guidance, payer strategy, and value storytelling
Need a smarter approach to commercialization and market access?
Our commercialization strategy and market access solutions help ensure speed to market through responsive, solutions-oriented strategies that help drive efficiency in execution and resource allocation to maximize patient access to appropriate therapies.
Connect with our team
Our team of leading value experts is dedicated to transforming evidence, policy insights, and market intelligence into effective global market access strategies. Let us help you navigate today’s complex healthcare landscape with confidence. Reach out to discover how we can support your goals.
